GB9924831D0 - Use of interferon alpha for treatment of asthma - Google Patents

Use of interferon alpha for treatment of asthma

Info

Publication number
GB9924831D0
GB9924831D0 GBGB9924831.2A GB9924831A GB9924831D0 GB 9924831 D0 GB9924831 D0 GB 9924831D0 GB 9924831 A GB9924831 A GB 9924831A GB 9924831 D0 GB9924831 D0 GB 9924831D0
Authority
GB
United Kingdom
Prior art keywords
asthma
treatment
interferon alpha
interferon
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9924831.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southampton
Original Assignee
University of Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southampton filed Critical University of Southampton
Priority to GBGB9924831.2A priority Critical patent/GB9924831D0/en
Publication of GB9924831D0 publication Critical patent/GB9924831D0/en
Ceased legal-status Critical Current

Links

GBGB9924831.2A 1999-10-21 1999-10-21 Use of interferon alpha for treatment of asthma Ceased GB9924831D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9924831.2A GB9924831D0 (en) 1999-10-21 1999-10-21 Use of interferon alpha for treatment of asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9924831.2A GB9924831D0 (en) 1999-10-21 1999-10-21 Use of interferon alpha for treatment of asthma

Publications (1)

Publication Number Publication Date
GB9924831D0 true GB9924831D0 (en) 1999-12-22

Family

ID=10863067

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9924831.2A Ceased GB9924831D0 (en) 1999-10-21 1999-10-21 Use of interferon alpha for treatment of asthma

Country Status (1)

Country Link
GB (1) GB9924831D0 (en)

Similar Documents

Publication Publication Date Title
EP1227821A4 (en) Therapeutic compositions and methods of use thereof
HUP0201393A3 (en) Use of xenon for treating neurointoxications
EP1404343A4 (en) Therapeutic combinations for the treatment of hormone deficiencies
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
IL162236A0 (en) Purified hepatitis c virus envelopeproteins for dagnostic and therapeutic use
IL147716A0 (en) Highly purified cytokine activating factor and methods of use
IL130171A0 (en) Therapeutic use of melatonin
NZ513686A (en) Treatment of trauma
IL144115A0 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
HUP0203315A3 (en) Process and intermediates for the preparation of isoxazolecaroxamides and analogues
PL359562A1 (en) Interferon for treatment of multiple sclerosis
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
GB9924831D0 (en) Use of interferon alpha for treatment of asthma
PL350963A1 (en) Use of arylalkanoylpyridazines
IL149170A0 (en) Use of nitric oxide for the treatment of airway constriction
GB9822885D0 (en) Use of interferon alpha for treatment of asthma
EP1158991A4 (en) Treatment of asthma
HU9802379D0 (en) Inhaler for treatment of asthma
NZ513823A (en) Treatment of asthma
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections
EP1230928A4 (en) Use of peptide
GB9926985D0 (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases
GB9910667D0 (en) New use of citreamicins
CA88062S (en) Set of cutlery
CA87150S (en) Set of cutlery

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)